Taiwan FDA registration 569d919e6e2c5ef621cd0e049dc86d0e

Beckman Coulter Apolipoprotein Correction Solution

TW: 貝克曼庫爾特協康載脂蛋白校正液
Taiwan flagTaiwan·Risk Class 2·BECKMAN COULTER INC.·Registered Oct 26, 2005 – Oct 26, 2020Cancelled
Registration details
Analysis ID
569d919e6e2c5ef621cd0e049dc86d0e
Customs Code
DHA00601328306
Company information
Manufacturer Country
United States
Product details
Intended Use
載脂蛋白校正液,結合Beckman Coulter 載脂蛋白 A-1和B試劑,用作SYNCHRON LX System上的校正.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Import Information
import
Dates and status
Registration Date
Oct 26, 2005
Expiry Date
Oct 26, 2020
Cancellation Date
Sep 13, 2018
Cancellation information
Status
Logged out
Reason
自請註銷
Companies making similar products

Top companies providing products similar to "Beckman Coulter Apolipoprotein Correction Solution"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Beckman Coulter Apolipoprotein Correction Solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 569d919e6e2c5ef621cd0e049dc86d0e and manufactured by BECKMAN COULTER INC.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BECKMAN COULTER INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations